Showing results (1221-1230 of 5,480) with videos related to

Sort By:
Pageof 548
Pharmacotherapy|February 10, 2006
Implications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitusBrian K Irons, Ronald Shane Greene, Timothy A Mazzolini, et al.
Pharmacotherapy|February 10, 2006
Reduced-dose rasburicase in the treatment of adults with hyperuricemia associated with malignancyDonald A Hutcherson, David C Gammon, Mansi S Bhatt, et al.
Pharmacotherapy|March 9, 2017
Role of Combination Antimicrobial Therapy for Vancomycin-Resistant Enterococcus faecium Infections: Review of the Current EvidenceJuwon Yim, Jordan R Smith, Michael J Rybak
Pharmacotherapy|November 9, 2021
Association of CYP2B6 genetic polymorphisms with bupropion and hydroxybupropion exposure: A systematic review and meta-analysisSeenae Eum, Franklin Sayre, Adam M Lee, et al.
Pharmacotherapy|October 31, 2012
Safety and immunogenicity of recombinant human thrombin: a pooled analysis of results from 10 clinical trialsNeil K Singla, Kevin N Foster, W Allan Alexander, et al.
Pharmacotherapy|October 31, 2012
Hemoglobin levels triggering erythropoiesis-stimulating agent therapy in patients with cancer: the shift after United States Food and Drug Administration policy changesKevin T Stroupe, Elizabeth Tarlov, Todd A Lee, et al.
Pharmacotherapy|January 7, 2014
Tissue plasminogen activator for the treatment of parapneumonic effusions in pediatric patientsEmily N Israel, Allison B Blackmer
Pharmacotherapy|January 7, 2014
Analysis of potential drug-drug interactions in medical intensive care unit patientsEsther V Uijtendaal, Lieke L M van Harssel, Gerard W K Hugenholtz, et al.
Pharmacotherapy|January 9, 2014
Clinical management strategies and implications for parenteral nutrition drug shortages in adult patientsTanna B Hassig, Brian P McKinzie, Christopher R Fortier, et al.
Pharmacotherapy|January 1, 1990
Hepatic failure associated with imipramine therapyM S Shaefer, A L Edmunds, R S Markin, et al.
Pageof 548